A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Etravirine D6 | CAS 1142096-06-7 - Request Quote

Picture of Etravirine D6

Etravirine D6

SZ CAT No:SZ-E038D04
CAS No
1142096-06-7
Mol.F.
C20H9D6BrN6O
Mol.Wt.
441.3
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Etravirine D6 is chemically 4-((6-Amino-5-bromo-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3,5-bis(methyl-d3)benzonitrile. Etravirine D6 is supplied with detailed characterization data compliant with regulatory guideline. Etravirine D6 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Etravirine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1142096-06-7

Purchase 1142096-06-7

Order 1142096-06-7

Enquire 1142096-06-7

price of 1142096-06-7

1142096-06-7 Supplier

1142096-06-7 Manufacturer

1142096-06-7 Exporter

buy high quality Etravirine D6

Purchase Etravirine D6

Etravirine D6 suppliers

Etravirine D6 manufacturers

Etravirine D6 price

Order Etravirine D6

Enquire Etravirine D6

Etravirine D6 cost

Etravirine D6 Supplier

Etravirine D6 Distributor

Etravirine D6 for Method Validation

Etravirine Reference Standard

Etravirine D6 for ANDA Filing

Etravirine D6 for Forced Degradation Studies

Etravirine D6 Identification Standards

Etravirine D6 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,